Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AndroGel in Adolescent Boys with Hypogonadism
NCT00193661Phase 2Completed
- Sponsor
- Solvay
- Start
- Aug 2002
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Testosterone TEPI patch in Hypogonadism and Constitutional delay of growth and puberty (CDGP), sponsored by Solvay. Started Aug 2002; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
HypogonadismConstitutional delay of growth and puberty (CDGP)
Beyond the preview
Go deeper on NCT00193661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00193661.